fibrinogen has been researched along with Carcinoma, Hepatocellular in 167 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (28.14) | 18.7374 |
| 1990's | 50 (29.94) | 18.2507 |
| 2000's | 23 (13.77) | 29.6817 |
| 2010's | 28 (16.77) | 24.3611 |
| 2020's | 19 (11.38) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Gao, N; Guo, Y; Li, GF; Qiao, H; Wang, C; Wang, T; Wen, Q; Xu, C; Yang, L; Zhang, Y; Zhou, J | 1 |
| Bai, T; Luo, XL; Mai, RY; Wu, GB | 1 |
| Chen, A; Dong, H; He, X; Hua, N; Ru, G; Tong, X; Wang, S; Yang, C; Zhou, F | 1 |
| Cai, X; Chen, J; Li, H; Tang, D; Zhang, P | 1 |
| Akashi, N; Hemmi, H; Kanda, T; Kobayashi, K; Maeta, N; Mitsui, I; Miyamae, J; Miyatake, S; Murakami, K; Okamura, Y; Saeki, K; Shinya, M | 1 |
| Chai, Z; Dong, W; Jin, J; Qiu, Z; Wang, J; Wang, X; Xia, Z; Yang, Z; Zhang, Q; Zhang, T | 1 |
| Chen, R; Chen, X; Gong, Q; Huang, B; Ji, H; Qian, Q; Wang, C; Xia, L; Yang, C; You, Z; Zhang, J; Zhao, Y | 1 |
| Dong, W; He, J; Lin, M; Lv, L; Sun, X; Xu, Y; Zhang, R; Zhang, X | 1 |
| Goethe, EA; Heimberger, AB; Rao, G | 1 |
| An, S; Li, L; Lu, Y; Wu, ZQ; Xu, HG; Xu, J | 1 |
| Fan, J; Li, F; Ren, Y; Zhou, J | 1 |
| Chen, J; Huang, J; Li, W; Luo, X; Ning, Q; Wan, X; Wang, M; Xi, D; Xu, M; Yang, M; Yuen, MF; Zhang, Z | 1 |
| Li, JJ; Li, K; Sun, JP; Wang, Q; Zhang, YH; Zhao, Y | 1 |
| Jiang, S; Jing, W; Lv, S; Ma, J; Ming, L; Peng, R; Zhu, M | 1 |
| Cheng, J; Dai, T; Fang, Z; Gao, Y; Kong, W; Wang, H; Wang, X; Xu, H; Zhang, J | 1 |
| Fang, T; Guo, M; Huang, P; Qi, F; Rao, Q; Sun, J; Xia, J; Yang, B; Yuan, F; Zhao, Z | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Wang, P; Wang, T; Xu, L; Xu, M; Zhang, J; Zhang, M | 1 |
| Guo, W; Li, M; Shui, Y; Wang, Z; Zhang, S; Zhu, L | 1 |
| Kim, SH; Lee, HJ; Park, SC; Shin, NR; Son, Y | 1 |
| Guo, R; Liu, X; Tian, J | 1 |
| Long, Q; Zhang, X | 1 |
| Abed, SY; El-Mesery, M; El-Mowafy, M; Elgaml, A; Youssef, LF | 1 |
| Gong, Z; Yan, C; Yang, Q | 1 |
| Bai, S; Ji, R; Ren, Q; Wang, Y; Zhou, Y | 2 |
| Chen, GH; Dou, KF; Jiang, N; Li, H; Li, HB; Li, JJ; Lv, Y; Tang, JX; Wang, GY; Yang, Y; Yi, HM; Yi, SH; Zeng, KN; Zhou, J | 1 |
| Chen, QG; Gao, QF; Jiang, YH; Li, SQ; Min, QH; Sun, F; Wang, XZ; Ying, HQ; Zhang, J; Zhang, L | 1 |
| Ibanez, IG; Klaus, F; Lohse, A; Meyer, B; Nagel, T; Wege, H | 1 |
| Binh, MT; Hoan, NX; Meyer, CG; Quyen, DT; Quyet, D; Son, HA; Song, LH; Toan, NL; Van Ba, N; Van Luong, H; Van Tong, H; Velavan, TP | 1 |
| Lin, YS; Shi, CS; Wu, K; You, MX; Yu, XX; Zhu, GQ | 1 |
| Fushiya, N; Imai, N; Iwaku, A; Kinoshita, A; Koike, K; Matsushima, M; Nishino, H; Oishi, M; Onoda, H; Tajiri, H; Tanaka, K | 1 |
| Bronson, RT; Cohen, DE; Demchev, V; Desai, A; Hornick, JL; Nayeb-Hashemi, H; Ukomadu, C | 1 |
| Jiang, N; Li, Y; Ruan, DY; Wang, GY; Yang, Y; Yi, HM | 1 |
| Guo, JR; Liu, Y; Shao, Y; Shen, HC; Su, YJ; Xu, F; Zhang, YW | 1 |
| Chen, GH; Jiang, N; Li, H; Wang, GS; Wang, GY; Yang, Y; Yi, HM; Zhang, J; Zhang, JW; Zhang, Q | 1 |
| Liu, J; Luo, X; Ning, Q; Wang, M; Xi, D | 1 |
| Chen, MG; Fu, SJ; Guo, ZY; Han, M; He, XS; Ji, F; Ju, WQ; Ma, Y; Ren, QQ; Wang, DP; Wang, XP; Wu, LW; Zhao, Q; Zhu, XF | 1 |
| Gao, H; Jiang, L; Liu, C; Qin, R; Wang, M; Xiao, G; Yan, L; Yang, J; Ye, D; Zhang, H; Zhu, F | 1 |
| Chen, F; Luo, XP; Ning, Q; Pi, B; Su, K; Xi, D; Xu, L; Yan, WM; Zeng, QL | 1 |
| Gu, J; Guo, L; Hu, L; Li, Y; Sun, S; Tian, X; Yang, S; Ye, M; Zhou, H; Zou, H | 1 |
| Cao, N; Ji, G; Li, JJ; Liu, X; Saiyin, H; Wen, Y; Wu, Y; Yin, F; Yu, L; Zuo, J | 1 |
| Ge, CH; Li, CY; Li, W; Li, YH; Wang, ZD; Xu, WX; Yang, XM; Yu, HT; Yu, M; Zhan, YQ | 1 |
| Bender, H; Haan, C; Haan, S; Heinrich, PC; Kato, N; Ludwig, S; Nordhoff, C; Schoenherr, C; Weiskirchen, R; Wiesinger, MY | 1 |
| Fan, BL; Liu, DL; Zhu, WL; Zhu, WX | 1 |
| Bai, X; Cao, L; Dong, N; Ruan, C; Wang, Z; Yu, Z; Zhang, W; Zhao, X | 1 |
| Fan, Y; Gao, TJ; Lou, MW; Wang, H | 1 |
| Attanasio, C; Dosch, R; Fish, RJ; Fort, A; Neerman-Arbez, M; Visel, A | 1 |
| Ha, KS; Jung, SH; Kim, YM; Kong, DH; Kwon, MH; Suh, IB | 1 |
| Cao, CZ; Cao, MM; Chen, H; Ge, CH; Li, CY; Li, W; Tang, LJ; Wang, XH; Wang, ZD; Xu, WX; Yang, XM; Yao, JW; Yu, M; Zhan, YQ | 1 |
| Fish, RJ; Neerman-Arbez, M | 1 |
| Liu, Y; Luo, X; Ning, Q; Wang, J; Wang, M; Wang, X; Xi, D; Xu, L; Yang, D; Zeng, Q | 1 |
| Abdo, AA; Gader, AG; Saja, MF; Sanai, FM; Shaikh, SA | 1 |
| Redman, CM; Xia, H | 1 |
| ALBERS, H; SCHMIDT, F | 1 |
| Fujita, M; Horinouchi, T; Inoue, E; Ishiguro, S; Ishihara, R; Kasugai, H; Kuroda, C; Maeda, H; Sasaki, Y; Yamada, T | 1 |
| Fan, BL; Luo, GS; Xu, CL; Zhao, WX; Zhu, WL; Zou, GL | 1 |
| Bas, S; Gabay, C; Gauthier, BR; Spenato, U; Stingelin, S | 1 |
| Dhillon, AP; Difford, J; Etessami, N; Quaglia, A; Sim, R | 1 |
| Albrecht, U; Bode, JG; Gehrmann, T; Grune, T; Häussinger, D; Lornejad-Schäfer, M; Poppek, D; Schliess, F | 1 |
| Bijzet, J; Doornbos-van der Meer, B; Limburg, PC; van Rijswijk, MH; Westra, J | 1 |
| Azuma, R; Demitsu, T; Hashimoto, T; Ishii, N; Jimbu, Y; Kakurai, M; Suzuki, M; Umemoto, N; Yamada, T; Yokokura, H; Yoneda, K | 1 |
| Borhis, G; Brackenbury, LS; Charleston, B; Hein, WR; Hunt, LG; Lefevre, EA; Monaghan, P; Richard, Y; Stamataki, Z; Supple, EA | 1 |
| Liu, Z; Ukomadu, C | 1 |
| Corral, J; de Arriba, F; Ferrer, F; González, M; Hernández-Espinosa, D; Martínez, C; Miñano, A; Mota, RA; Ordoñez, A; Pérez-Ceballos, E; Vicente, V | 1 |
| Kudryk, B; Redman, CM; Sher, B; Yu, S | 2 |
| Cappellato, G; Dal Bo Zanon, R; Farinati, F; Girolami, A; Levi Minzi, S; Pengo, V | 1 |
| Itakura, M; Iwamura, K; Kamiguchi, H; Katsunuma, T; Matsuzaki, S | 1 |
| Fair, DS; Plow, EF | 1 |
| Ballard, JO; Eyster, ME; Kelly, GA; Kukrika, MD; Sanders, JC | 1 |
| Mierau, GW; Orsini, EN | 1 |
| Aden, D; Arnaout, MA; Colten, HR; Goldberger, G; Kay, R; Rits, M | 1 |
| Cao, Z; Chung, DW; Davie, EW; Hu, CH; Loeb, KR; Mizuguchi, J | 1 |
| Katsuda, S; Nakanishi, I; Oda, Y | 1 |
| Hammacher, A; Simpson, RJ; Treutlein, H; Ward, LD; Weinstock, J; Yasukawa, K | 1 |
| Bíró, J; Falus, A; Fehér, KG; Rákász, E | 1 |
| Garcia, D; Pan, H; Patel, K; Rayanade, RJ; Sehgal, PB; Wang, L | 1 |
| Fujiwara, Y; Gotoh, M; Hasuike, Y; Higaki, N; Kanai, T; Kishi, K; Sakon, M; Takeda, Y; Taniguchi, K; Yamada, T | 1 |
| Biró, J; Bösze, S; Falus, A; Hudecz, F; Nagy, Z; Rajnavölgyi, E; Rákász, E; Schmidt, B | 1 |
| Gabay, C; Genin, B; Guerne, PA; Iynedjian, PB; Mentha, G; Roux-Lombard, P | 1 |
| Barbacane, RC; Bartle, L; Conti, P; Reale, M; Sipe, JD | 1 |
| Gotoh, M; Hanike, Y; Kanai, T; Kita, Y; Monden, M; Monden, T; Nakamura, H; Sakon, M; Umeshita, K; Yoshida, T | 1 |
| Collet, JP; Mirshahi, SS; Soria, C; Soria, J; Vannier, JP; Vasse, M | 1 |
| Bartle, LM; Loose, LD; Rokita, H; Sipe, JD | 1 |
| Ishizaka, S; Tsujii, T | 1 |
| Gotoh, M; Hasuike, Y; Kanai, T; Monden, M; Monden, T; Murakami, T; Nakamura, H; Nakano, H; Sakon, M; Umeshita, K | 1 |
| de Noronha, F; Hotchkiss, JH; Jacob, JR; Liu, RH; Roneker, CA; Tennant, BC | 1 |
| Anderson, GM; Shafer, JA; Shaw, AR | 1 |
| Sefton, MV; Uludag, H | 1 |
| Gotoh, M; Hirohashi, S; Kitajima, M; Sasaki, H; Terada, M; Yamamoto, T | 1 |
| Gotoh, M; Hasuike, Y; Kanai, T; Miyamoto, A; Monden, M; Nakano, H; Sakon, M; Takiguchi, S; Umeshita, K; Yokoyama, S | 1 |
| Høstmark, AT; Kierulf, P; Kiserud, CE | 1 |
| Cao, Z; Chung, DW; Davie, EW; Huang, S | 1 |
| Collet, JP; Paysant, J; Soria, C; Soria, J; Vannier, JP; Vasse, M | 1 |
| Haidaris, PJ | 1 |
| Amemiya, N; Endo, T; Kume, S; Matsumoto, Y; Mizoe, A; Ozaki, Y; Yamamoto, M; Yatomi, Y; Yoda-Endo, M; Yuminamochi, T | 1 |
| Alessandri, C; Andreozzi, P; Basili, S; Cara, D; Cordova, C; Maurelli, M; Vieri, M | 1 |
| Berthier, F; Kushner, I; Lozanski, G | 1 |
| Dono, K; Eguchi, H; Gotoh, M; Monden, M; Monden, T; Ohzato, H; Sakon, M; Takeda, T; Umeshita, K | 1 |
| Cindoruk, M; Doğan, UB; Dumlu, S; Unal, S; Unlü, R | 1 |
| Binsack, R; Dörge, L; Stegmeier, K; Völkl, A | 1 |
| Kagawa, T; Matsuzaki, S; Nakano, A; Nishizaki, Y; Takashimizu, S; Tanaka, Y; Uchiyama, J; Watanabe, N | 1 |
| Asselta, R; Duga, S; Malcovati, M; Modugno, M; Tenchini, ML | 1 |
| Falus, A; Fejér, G; Igaz, P; Madurka, I; Rose-John, S; Szalai, C; Tóth, S | 1 |
| Karlsson, JO; Toner, M; Yarmush, ML | 1 |
| Bosze, S; Falus, A; Hudecz, F; Kajtár, J; Szabó, R | 1 |
| Brown, ET; Fuller, GM | 1 |
| Fett, JW; Olson, KA; Verselis, SJ | 1 |
| Bernat, A; Chatenet-Duchène, L; Herbert, JM | 1 |
| Rybarczyk, BJ; Simpson-Haidaris, PJ | 1 |
| Chung, MJ; Kang, MJ; Lee, DG; Moon, WS; Yu, HC | 1 |
| Gotoh, M; Kanai, T; Miyamoto, A; Monden, M; Nakamura, H; Sakon, M; Takeda, T; Umeshita, K; Wakasa, K; Yoshida, T | 1 |
| Bösze, S; Falus, A; Hudecz, F; Igaz, P; Tóth, S | 1 |
| Gabriel, DA; Roberts, HR; Stinchcombe, TE | 1 |
| Chang, FR; Chen, CY; Chia, YC; Chiu, HF; Hsieh, TJ; Lin, HC; Wu, YC | 1 |
| Sarcione, EJ; Smalley, JR | 1 |
| Damrongsak, C; Jaidat, I; Leelarasamee, A; Wasantapruek, S | 1 |
| Abe, K; Endo, E; Fujimoto, H; Fukuoka, Y; Khato, J | 1 |
| Dymock, IW; Green, G; Poller, L; Thomson, JM | 1 |
| Bagshawe, AF; Barr, RD; Ouna, N; Simpson, JG | 1 |
| Lechner, K; Niessner, H; Thaler, E | 1 |
| Johnson, PJ; White, Y; Williams, R; Woolf, IL | 1 |
| Abe, K; Endo, E; Fukuoka, Y; Khato, J; Ohta, E; Sato, H; Sato, T | 1 |
| Abrams, E; Givelber, H; Gralnick, HR | 1 |
| Chelucci, C; Hassan, JH; Peschle, C; Sorrentino, V | 1 |
| Gotoh, M; Kanai, T; Monden, M; Monden, T; Mori, T; Sakon, M; Shimizu, J; Tarui, T; Tomoda, K; Umeshita, K | 1 |
| Brisigotti, M; Callea, F; Cozzutto, C; Fabbretti, G | 1 |
| Ganapathi, MK | 1 |
| Kaptein, A; Princen, HM; Roodenburg, L | 1 |
| Vanderburg, G; Weinstein, JA | 1 |
| Bergonzelli, GE; Kruithof, EK | 1 |
| Brabenec, A; Ganapathi, MK; Kelley, MF; Kushner, I; Mackiewicz, A; Schultz, D; Weinstein, J | 1 |
| Ganapathi, MK; Kushner, I; Mackiewicz, A; Speroff, T | 1 |
| Evans, SW; Harrison, SP; Thompson, D; Whicher, JT | 1 |
| Hino, F; Katayama, M; Kato, I; Kurome, T; Uchida, H; Yamamoto, K | 1 |
| Hatabu, H; Hidaka, A; Iida, Y; Katsushima, S; Konishi, J; Kusui, T; Nakagawa, K; Oi, H | 1 |
| Dufhues, G; Heinrich, PC; Hipp, E; Hirano, T; Kishimoto, T; Lenz, D; Rose-John, S; Schiel, X; Schmitz, H; Schooltink, H | 1 |
| Carey, LC; Clausen, KP; Teitelbaum, DH; Tuttle, S | 1 |
| Lipmann, F; Liu, MC; Redman, CM; Sy, J; Yu, S | 1 |
| Antico, S; Callegari, F; Cappellato, M; Girolami, A; Pengo, V; Ruffato, G | 1 |
| Kakizoe, S; Kojiro, M; Nakashima, T | 1 |
| Bereta, J; Czuba-Pelech, B; Gauldie, J; Koj, A; Magielska-Zero, D; Pajdak, W | 1 |
| Gotoh, M; Kambayashi, J; Kobayashi, K; Monden, M; Mori, T; Okamura, J; Sakon, M | 1 |
| Baumann, H; Jahreis, GP; Won, KA | 1 |
| Lai, EC; Ng, IO; Ng, M; Wu, PC | 1 |
| Hortin, GL | 1 |
| Goodman, ZD; Ishak, KG; Langloss, JM; Rabin, L; Sesterhenn, IA | 1 |
| Bassi, N; D'Amico, D; Farinati, F; Naccarato, R; Pengo, V | 1 |
| Baumhueter, S; Courtois, G; Crabtree, GR | 1 |
| Bambach, CP; Eckstein, RP; Goodman, BN; Roche, J; Stiel, D | 1 |
| Bellisola, G; Casaril, M; Corrocher, R; Gabrielli, GB; Miatto, O; Nicoli, N | 1 |
| Barsigian, C; Base, W; Fish, S; Gilman, P; Martinez, J; Schaeffer, A | 1 |
| Cortés, JM; Oliva, H; Ordi Majá, J; Sarasa Corral, JL | 1 |
| Kong, V; Kudryk, B; Redman, C; Yu, S | 1 |
| Canellos, GP; Engelman, K; Hull, E; O'Connor, GT; Primack, A; Wilson, J | 1 |
| Freeman, T; McFarlane, AS; Rake, MO; Williams, R | 1 |
| Bahr, R; Bell, W; Carbone, PP; Waldmann, TA | 1 |
| Frick, PG; Straub, PW; von Felten, A | 2 |
| Mosesson, MW | 1 |
| Mester, L; Soria, J; Szabados, L | 1 |
| Ansari, A; Silvis, SE | 1 |
| Asofsky, R; Becker, FF; Klein, KM | 1 |
| Molla, A; van Damme, B; Verhaeghe, R; Vermylen, J | 1 |
| Masseyeff, R; Quelin, S; Rioche, M | 1 |
| Bayer, R; Gladigau, V; Ruhenstroth-Bauer, G; von Boehmer, H | 1 |
7 review(s) available for fibrinogen and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Prognostic significance of pretreatment plasma fibrinogen level in patients with digestive system tumors: a meta-analysis.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Colorectal Neoplasms; Digestive System Neoplasms; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fibrinogen; Humans; Liver Neoplasms; Prognosis; Stomach Neoplasms | 2018 |
Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas: A meta-analysis.
Topics: Carcinoma, Hepatocellular; Fibrinogen; Humans; Liver Neoplasms; Pancreatic Neoplasms; Patient Care Management; Predictive Value of Tests; Prognosis | 2018 |
Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk.
Topics: Arteriosclerosis; Biomarkers; Carcinoma, Hepatocellular; Cytokines; Endothelium, Vascular; Fibrinogen; Gene Expression Regulation; Humans; Interleukin-6; Liver; Liver Neoplasms; Models, Biological; Monocytes; Oncostatin M; Peptide Biosynthesis; Peptides; Risk; Thrombosis; Tumor Cells, Cultured | 1996 |
[Effect of drainage and injection factor XIII with fibrinogen for hepatic biloma resulting from transcatheter arterial embolization in patients with hepatocellular carcinoma--report of two cases].
Topics: Aged; Bile; Bile Duct Diseases; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Drainage; Embolization, Therapeutic; Factor XIII; Fibrinogen; Hepatic Artery; Humans; Injections; Liver Neoplasms; Male | 1998 |
The dysfibrinogenaemias.
Topics: Afibrinogenemia; Blood Coagulation Tests; Carcinoma, Hepatocellular; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Liver Neoplasms; Mutation; Thrombosis | 2001 |
Histological diagnosis of hepatocellular carcinoma.
Topics: alpha-Fetoproteins; Bile; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Clone Cells; Diagnosis, Differential; Fibrinogen; Histological Techniques; Humans; Liver; Liver Neoplasms; Neoplasm Proteins | 1992 |
8 trial(s) available for fibrinogen and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Female; Fibrinogen; Hepatectomy; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Monocytes; Neutrophils; Prealbumin; Preoperative Care; Prognosis; Treatment Outcome | 2019 |
Effect of Acute Normovolemic Hemodilution Combined with Controlled Low Central Venous Pressure on Blood Coagulation Function and Blood Loss in Patients Undergoing Resection of Liver Cancer Operation.
Topics: Adult; Aged; Anemia; Arterial Pressure; Blood Loss, Surgical; Blood Transfusion; Carcinoma, Hepatocellular; Central Venous Pressure; Female; Fibrinogen; Hematocrit; Hemodilution; Hemoglobins; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Thrombin Time | 2015 |
[A preliminary clinical study on the treatment of primary hepatic carcinoma by transcatheter arterial perfusion of batroxobin combined with TACE].
Topics: Adult; Aged; Batroxobin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Disease-Free Survival; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 2010 |
The coagulopathy of liver disease: does vitamin K help?
Topics: Adult; Aged; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Factor VII; Female; Fibrinogen; Hemorrhagic Disorders; Hepatitis B, Chronic; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Protein C; Protein Precursors; Protein S; Prothrombin; Treatment Outcome; Vitamin K; Young Adult | 2013 |
Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin.
Topics: Alleles; alpha 1-Antitrypsin; Animals; Antineoplastic Agents; Antithrombins; Boronic Acids; Bortezomib; Carcinoma, Hepatocellular; Case-Control Studies; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Endoplasmic Reticulum; Factor Xa Inhibitors; Fibrinogen; Humans; Immunohistochemistry; Injections, Intravenous; Leukocyte Elastase; Liver; Liver Neoplasms; Male; Mice; Molecular Chaperones; Multiple Myeloma; Proteasome Inhibitors; Proteins; Pyrazines; Serpins; Ubiquitin | 2008 |
[The efficacy of transarterial immuno-embolization therapy in patients with unresectable hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Fibrinogen; Humans; Immunotherapy; Infusions, Intra-Arterial; Liver Neoplasms; Picibanil | 1995 |
[Immunological and histological analyses of transarterial immuno-embolization therapy (TIE) in operable patients with hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Fibrinogen; Hepatic Artery; Humans; Interleukin-6; Interleukin-8; Liver Neoplasms; Lymphocyte Subsets; Picibanil; Tumor Necrosis Factor-alpha | 1994 |
153 other study(ies) available for fibrinogen and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Stat4 rs7574865 polymorphism promotes the occurrence and progression of hepatocellular carcinoma via the Stat4/CYP2E1/FGL2 pathway.
Topics: Animals; Carcinoma, Hepatocellular; Case-Control Studies; Cytochrome P-450 CYP2E1; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Liver Neoplasms; Mice; Polymorphism, Single Nucleotide; Proteomics; STAT4 Transcription Factor | 2022 |
Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomy.
Topics: Albumins; alpha-Fetoproteins; Carcinoma, Hepatocellular; Fibrinogen; Hepatectomy; Humans; Inflammation; Liver Neoplasms; Lymphocytes; Neutrophils; Prognosis; Retrospective Studies | 2022 |
The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Fibrinogen; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Liver Neoplasms | 2022 |
Evaluation of Serum FGL1 as Diagnostic Markers for HBV-Related Hepatocellular Carcinoma.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Fibrinogen; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms | 2023 |
Expression profile of immunoregulatory factors in canine tumors.
Topics: Animals; B7-H1 Antigen; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Dog Diseases; Dogs; Fibrinogen; Immunity; L-Amino Acid Oxidase; Liver Neoplasms; OX40 Ligand | 2022 |
Proteomic analysis of small extracellular vesicles from the plasma of patients with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Complement C1q; Complement C4b-Binding Protein; Extracellular Vesicles; Fibrinogen; Humans; Liver Neoplasms; Proteomics | 2022 |
Fibrinogen-like protein 1 promotes liver-resident memory T-cell exhaustion in hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Fibrinogen; Humans; Liver Neoplasms; Mice; T-Cell Exhaustion; Tumor Microenvironment | 2023 |
Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma.
Topics: Animals; B7-H1 Antigen; Carcinoma, Hepatocellular; Fibrinogen; Immunotherapy; Liver Neoplasms; Mice; Sirtuin 2 | 2023 |
Aspirin and immunotherapy: a Faustian bargain?
Topics: Aspirin; Carcinoma, Hepatocellular; Fibrinogen; Humans; Immunotherapy; Liver Neoplasms | 2023 |
Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma.
Topics: Albumins; alpha-Fetoproteins; Bilirubin; Carcinoma, Hepatocellular; Fibrinogen; Hepatectomy; Humans; Liver Neoplasms; Lymphocytes; Prognosis; Retrospective Studies | 2023 |
The predictive value of the preoperative albumin-to-fibrinogen ratio for postoperative hospital length of stay in liver cancer patients.
Topics: Adult; Albumins; Bilirubin; Carcinoma, Hepatocellular; Fibrinogen; Hospitals; Humans; Length of Stay; Liver Neoplasms; Prognosis; Retrospective Studies | 2023 |
Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity.
Topics: Animals; Antibodies, Monoclonal; Biomarkers; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytokines; Cytotoxicity, Immunologic; Dendritic Cells; Disease Models, Animal; Female; Fibrinogen; Heterografts; Humans; Immunophenotyping; Liver Neoplasms; Mice; Mice, Knockout; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; T-Lymphocytes, Cytotoxic | 2019 |
[Prognostic value of combined preoperative fibrinogen and platelet-lymphocyte ratio in patients with early recurrent hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Female; Fibrinogen; Hepatitis B; Humans; Liver Neoplasms; Lymphocyte Count; Male; Neoplasm Recurrence, Local; Platelet Count; Prognosis; Proportional Hazards Models; Retrospective Studies | 2019 |
Differential Expression and Diagnostic Significance of Pre-Albumin, Fibrinogen Combined with D-Dimer in AFP-Negative Hepatocellular Carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Neoplasms; Male; Middle Aged; Prealbumin; Sensitivity and Specificity | 2020 |
The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
Topics: Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Neutrophils; Prognosis; Retrospective Studies; ROC Curve | 2020 |
Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8
Topics: B7-H1 Antigen; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Fibrinogen; Humans; Liver Neoplasms; Prognosis | 2020 |
Development and validation of a prognostic model based on the albumin-to-fibrinogen ratio (AFR) and gamma-glutamyl transpeptidase-to-platelet ratio (GPR) in hepatocellular carcinoma patients.
Topics: Albumins; Carcinoma, Hepatocellular; China; Fibrinogen; gamma-Glutamyltransferase; Humans; Liver Neoplasms; Prognosis | 2020 |
Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Apolipoprotein A-I; Apolipoprotein B-100; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Movement; Computational Biology; Down-Regulation; Fibrinogen; Humans; Liver Neoplasms; Middle Aged; Retinol-Binding Proteins, Plasma; Survival Analysis; T-Lymphocytes | 2021 |
Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells.
Topics: Apoptosis; Autophagy; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Fibrinogen; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Liver Neoplasms; MAP Kinase Signaling System; Niacinamide; Phenylurea Compounds; Signal Transduction; Sorafenib | 2021 |
Association of Plasma Fibrinogen Levels on Postoperative Day 1 with 2-Year Survival of Orthotopic Liver Transplantation for HBV-Related HCC.
Topics: Ascites; Carcinoma, Hepatocellular; Fibrinogen; Hepatitis B; Hepatitis B virus; Humans; Liver Neoplasms; Liver Transplantation | 2022 |
Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fibrinogen; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Portal Vein; Prognosis; Retrospective Studies; Survival Analysis | 2017 |
Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
Topics: Aspartate Aminotransferases; Bilirubin; Carcinoma, Hepatocellular; Egypt; Fas Ligand Protein; Fibrinogen; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-gamma; Liver Neoplasms; Middle Aged; Serum Albumin; Solubility | 2017 |
Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Disease Progression; Fibrinogen; Hepatic Stellate Cells; Hepatocytes; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Oncogenes; Receptors, Vitronectin; Signal Transduction; Zebrafish | 2018 |
Preoperative Alfa-Fetoprotein and Fibrinogen Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation Regardless of the Milan Criteria: Model Development with External Validation.
Topics: alpha-Fetoproteins; Area Under Curve; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Models, Theoretical; Neoplasm Recurrence, Local; Preoperative Period; Retrospective Studies; Risk Factors; ROC Curve | 2018 |
Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma-correlation with liver cancer and liver cirrhosis.
Topics: Carcinoma, Hepatocellular; Fibrinogen; Glycosylation; Humans; Liver Cirrhosis; Liver Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Reference Standards; Time Factors | 2018 |
Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma, Hepatocellular; Case-Control Studies; Disease Progression; Female; Fibrinogen; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Solubility; Young Adult | 2018 |
[Analysis of risk factors for spontaneous rupture of hepatocellular carcinoma].
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Liver Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Retrospective Studies; Risk Factors; Rupture, Spontaneous | 2013 |
Elevated plasma fibrinogen levels are associated with a poor prognosis in patients with hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Hepatocellular; Female; Fibrinogen; Hospitals, University; Humans; Japan; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors | 2013 |
Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
Topics: Animals; Apoptosis Regulatory Proteins; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; Fibrinogen; Gene Expression Regulation, Neoplastic; Liver; Liver Neoplasms; Mice; Mice, Knockout; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function.
Topics: Adult; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Fibrinogen; Hepatectomy; Hepatitis B Surface Antigens; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Models, Biological; Neoplasm Recurrence, Local; Predictive Value of Tests; Preoperative Period; Retrospective Studies; Risk Factors; ROC Curve; Tumor Burden | 2015 |
Pretransplant Elevated Plasma Fibrinogen Level is a Novel Prognostic Predictor for Hepatocellular Carcinoma Recurrence and Patient Survival Following Liver Transplantation.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fibrinogen; Follow-Up Studies; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Period; Prognosis; Retrospective Studies; ROC Curve; Survival Analysis | 2016 |
Adenovirus-mediated artificial microRNA against human fibrinogen like protein 2 inhibits hepatocellular carcinoma growth.
Topics: Adenoviridae; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Fibrinogen; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; RNA Interference; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Liver Neoplasms; Liver Transplantation; Lymphocyte Count; Male; Middle Aged; Neutrophils; Preoperative Period; Prognosis; Retrospective Studies; Survival Analysis; Tumor Burden; Young Adult | 2017 |
Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.
Topics: Adult; Area Under Curve; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Female; Fibrinogen; Hepatectomy; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Count; Preoperative Period; Prospective Studies; Prothrombin; Regression Analysis; Retrospective Studies | 2017 |
Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma.
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Disease Models, Animal; Endothelial Cells; Female; Fibrinogen; Humans; Interferon-gamma; Interleukin-2; Leukemia, Monocytic, Acute; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; RNA, Messenger; Thrombophilia; Thromboplastin | 2008 |
Profiling of endogenous serum phosphorylated peptides by titanium (IV) immobilized mesoporous silica particles enrichment and MALDI-TOFMS detection.
Topics: Adult; Blood Proteins; Carcinoma, Hepatocellular; Caseins; Fibrinogen; Humans; Liver Neoplasms; Organophosphonates; Peptide Fragments; Phosphopeptides; Phosphorylation; Silicon Dioxide; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Titanium | 2009 |
Proapoptotic function of integrin beta(3) in human hepatocellular carcinoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Fibrinogen; Humans; Integrin beta3; Liver Neoplasms; Vitronectin | 2009 |
Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; CREB-Binding Protein; Down-Regulation; Fibrinogen; Gene Deletion; Gene Expression Regulation, Neoplastic; Hepatocyte Nuclear Factor 1-alpha; HMGB1 Protein; Humans; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Protein Binding; Response Elements; STAT3 Transcription Factor; Transcription, Genetic | 2009 |
Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes.
Topics: Animals; Antimicrobial Cationic Peptides; Carcinoma, Hepatocellular; Cell Line, Tumor; Fibrinogen; Gene Expression Regulation; Hepatocytes; Hepcidins; Humans; Interferon-gamma; Interleukins; Liver Neoplasms; Male; Rats; Rats, Sprague-Dawley; STAT1 Transcription Factor; STAT3 Transcription Factor; Virus Replication | 2009 |
Abnormal expression of fibrinogen gamma (FGG) and plasma level of fibrinogen in patients with hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Base Sequence; Blotting, Northern; Carcinoma, Hepatocellular; DNA Primers; Female; Fibrinogen; Humans; Liver Neoplasms; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Young Adult | 2009 |
Hyperfibrinogenemia and prolonged clotting times in a Turner syndrome patient with hepatocellular carcinoma.
Topics: Blood Coagulation; Blood Coagulation Tests; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Time Factors; Turner Syndrome; Young Adult | 2010 |
A liver enhancer in the fibrinogen gene cluster.
Topics: Animals; Animals, Genetically Modified; Carcinoma, Hepatocellular; Cells, Cultured; Conserved Sequence; Embryo, Mammalian; Embryo, Nonmammalian; Enhancer Elements, Genetic; Fibrinogen; Green Fluorescent Proteins; Humans; In Situ Hybridization; Kidney; Liver Neoplasms; Mice; Multigene Family; Regulatory Sequences, Nucleic Acid; Zebrafish | 2011 |
Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma.
Topics: Amines; Biomarkers, Tumor; Biotin; Blood Specimen Collection; Carcinoma, Hepatocellular; Factor XIII; Fibrinogen; Hepatitis; Humans; Immobilized Proteins; Isoniazid; Limit of Detection; Liver Cirrhosis; Liver Neoplasms; Protein Array Analysis; Reproducibility of Results; Serologic Tests; Time Factors | 2011 |
Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms.
Topics: Antibodies, Neutralizing; Blotting, Western; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Hep G2 Cells; Hepatocytes; Humans; Liver Neoplasms; Neoplasm Proteins; Signal Transduction | 2011 |
A novel regulatory element between the human FGA and FGG genes.
Topics: Animals; Animals, Genetically Modified; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromatin Immunoprecipitation; Chromosome Mapping; Conserved Sequence; Enhancer Elements, Genetic; Fibrinogen; Gene Expression Regulation; Genes, Reporter; Genes, Synthetic; Green Fluorescent Proteins; HEK293 Cells; Hep G2 Cells; Hepatocytes; Humans; Larva; Liver Neoplasms; Luciferases; Mice; Recombinant Fusion Proteins; Transgenes; Zebrafish | 2012 |
Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Fibrin; Fibrinogen; Flow Cytometry; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Mice; Mice, Nude; MicroRNAs; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thromboplastin | 2012 |
Oxysterols suppress constitutive fibrinogen expression.
Topics: Acute-Phase Reaction; alpha 1-Antitrypsin; Animals; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cholesterol; DNA-Binding Proteins; Feedback, Physiological; Fibrinogen; Gene Expression Regulation; Hepatocytes; Humans; Hydroxycholesterols; Interleukin-6; Liver Neoplasms; Liver Neoplasms, Experimental; Liver X Receptors; Orphan Nuclear Receptors; Rats; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Sulfonamides; Transcription Factors; Transfection; Tumor Cells, Cultured | 2003 |
[ON THE FIBRINOGEN CONTENT OF THE PLASMA OF TUMOR-BEARING AND NORMAL RATS].
Topics: Animals; Blood Chemical Analysis; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Fibrinogen; Liver Neoplasms; Neoplasms; Rats; Research; Sarcoma, Experimental; Sarcoma, Yoshida | 1963 |
T2-shortening effect of fibrinogen inclusions on MRI of hepatocellular carcinoma: case report and experimental relaxation measurement.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Inclusion Bodies; Liver Neoplasms; Magnetic Resonance Imaging; Phantoms, Imaging | 2004 |
[Cloning and identification of fibrinogen gamma polypeptide (FGG) gene differentially expressed in human hepatocellular carcinoma].
Topics: Base Sequence; Carcinoma, Hepatocellular; Cloning, Molecular; DNA, Complementary; Fibrinogen; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
CD14 is an acute-phase protein.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Adult; Aged; Animals; Arthritis, Reactive; Arthritis, Rheumatoid; C-Reactive Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Dexamethasone; Fibrinogen; Hepatocytes; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Lipopolysaccharide Receptors; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Receptors, Interleukin-1; Receptors, Interleukin-6; Rheumatic Diseases; RNA, Messenger; Severity of Illness Index; Sialoglycoproteins; Solubility; Synovial Fluid; Tumor Necrosis Factor-alpha; Turpentine | 2004 |
Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis: A wolf in sheep's clothing?
Topics: Actins; Adult; Biomarkers, Tumor; Carcinoma, Hepatocellular; Endothelium, Vascular; Factor XIIIa; Female; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Receptors, Complement 3b | 2005 |
Osmotic regulation of STAT3 stability in H4IIE rat hepatoma cells.
Topics: alpha-Macroglobulins; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Fibrinogen; Gene Expression Regulation; Liver Neoplasms; Osmosis; Phosphorylation; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation; Ubiquitins | 2005 |
Differential influence of p38 mitogen activated protein kinase (MAPK) inhibition on acute phase protein synthesis in human hepatoma cell lines.
Topics: Acute-Phase Proteins; Analysis of Variance; Blotting, Western; C-Reactive Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Complement C3; Fibrinogen; Humans; Imidazoles; Immunization; Interleukin-1; Liver Neoplasms; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serum Amyloid A Protein; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha | 2006 |
Paraneoplastic pemphigus mimicking erosive mucosal lichen planus associated with primary hepatocellular carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Desmoglein 1; Desmoglein 3; Desmosomes; Fibrinogen; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin G; Keratinocytes; Lichen Planus; Lichen Planus, Oral; Lip Diseases; Liver Neoplasms; Male; Membrane Proteins; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Penile Diseases; Plakins; Protein Precursors | 2006 |
Fibrinogen is localized on dark zone follicular dendritic cells in vivo and enhances the proliferation and survival of a centroblastic cell line in vitro.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Burkitt Lymphoma; Carcinoma, Hepatocellular; Cattle; Cell Differentiation; Cell Proliferation; Cell Survival; Dendritic Cells, Follicular; Fibrinogen; Germinal Center; Humans; Immunization; Liver Neoplasms; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Palatine Tonsil; Receptors, Antigen, T-Cell, gamma-delta; Sequence Homology, Amino Acid; Sheep; Signal Transduction; T-Lymphocytes; Tumor Cells, Cultured | 2007 |
Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Fibrinogen; Gene Expression Regulation, Neoplastic; Hepatocytes; Humans; Interleukin-6; Neoplasm Proteins | 2008 |
Fibrinogen precursors. Order of assembly of fibrinogen chains.
Topics: Carcinoma, Hepatocellular; Cell Line; Fibrinogen; Humans; Kinetics; Liver Neoplasms; Macromolecular Substances; Polyribosomes; Protein Precursors | 1984 |
The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
Topics: Adult; Afibrinogenemia; Aged; Blood Coagulation Tests; Carcinoma, Hepatocellular; Diagnosis, Differential; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Thrombin Time | 1984 |
A clinical evaluation of serum alpha-1-antichymotrypsin levels in liver disease and cancers.
Topics: alpha 1-Antichymotrypsin; alpha-Fetoproteins; Blood Sedimentation; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Chymotrypsin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Sialic Acids | 1981 |
Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line.
Topics: Albumins; alpha-2-Antiplasmin; Blood Proteins; Carcinoma, Hepatocellular; Cell Line; Epitopes; Fibrinogen; Glycoproteins; Humans; Kinetics; Liver Neoplasms; Plasminogen; Proteins; Radioimmunoassay | 1983 |
Acquired dysfibrinogenemia in a hemophiliac with hepatoma: resolution of fibrinogen dysfunction following chemotherapy.
Topics: Adolescent; Antineoplastic Agents; Blood Coagulation Disorders; Carcinoma, Hepatocellular; Fibrinogen; Hemophilia A; Hemophilia B; Humans; Liver Neoplasms; Male; Neoplasm Metastasis; Recurrence | 1981 |
Intracellular assembly of human fibrinogen.
Topics: Carcinoma, Hepatocellular; Cell Line; Fibrinogen; Humans; Kinetics; Liver Neoplasms; Macromolecular Substances; Molecular Weight | 1983 |
Diagnosis of human tumors. Case 1: Hepatocarcinoma, fibrolamellar type.
Topics: Carcinoma, Hepatocellular; Child; Female; Fibrinogen; Humans; Liver; Liver Neoplasms; Microscopy, Electron | 1983 |
Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines.
Topics: Animals; Blood Proteins; Carcinoma, Hepatocellular; Cell Line; Complement C3b Inactivator Proteins; Complement C4b; Female; Fibrinogen; Humans; Kinetics; Liver Neoplasms; Macromolecular Substances; Molecular Weight; Oocytes; Protein Biosynthesis; RNA, Messenger; Xenopus | 1984 |
Characterization of the 5'-flanking region of the gene for the gamma chain of human fibrinogen.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Carcinoma, Hepatocellular; Cell Line; Chloramphenicol O-Acetyltransferase; CHO Cells; Cricetinae; DNA-Binding Proteins; Fibrinogen; Gene Expression; Humans; Interleukin-6; Liver Neoplasms; Macromolecular Substances; Molecular Sequence Data; Promoter Regions, Genetic; Recombinant Proteins; Regulatory Sequences, Nucleic Acid; Sequence Deletion; TATA Box; Transfection; Tumor Cells, Cultured | 1995 |
An autopsy case of hepatic sarcomatoid tumor: immunohistochemical comparison with a sarcomatous component of hepatocellular carcinoma.
Topics: Aged; Albumins; alpha 1-Antitrypsin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Immunohistochemistry; Keratins; Liver Neoplasms; Male; Membrane Glycoproteins; Middle Aged; Mucin-1; Sarcoma; Vimentin | 1994 |
Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Biosensing Techniques; Carcinoma, Hepatocellular; Circular Dichroism; Fibrinogen; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-6; Liver Neoplasms; Lymphocyte Activation; Mice; Models, Molecular; Multiple Myeloma; Protein Binding; Protein Conformation; Receptors, Interleukin; Receptors, Interleukin-6; Recombinant Fusion Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Structure-Activity Relationship; Tumor Cells, Cultured | 1994 |
Dehydroepiandrosterone modulates the spontaneous and IL-6 stimulated fibrinogen production of human hepatoma cells.
Topics: Carcinoma, Hepatocellular; Dehydroepiandrosterone; Dexamethasone; Fibrinogen; Humans; Immunologic Factors; Interleukin-6; Liver Neoplasms; Recombinant Proteins; Tumor Cells, Cultured | 1995 |
Modulation of interleukin-6-induced plasma protein secretion in hepatoma cells by p53 species.
Topics: alpha 1-Antitrypsin; Animals; Blood Proteins; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Chloramphenicol O-Acetyltransferase; DNA-Binding Proteins; Fibrinogen; Humans; Interleukin-6; Liver Neoplasms; Mice; Nuclear Proteins; Plasmids; Recombinant Proteins; Transcription Factors; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
The effect of WSEWS pentapeptide and WSEWS-specific monoclonal antibodies on constitutive and IL-6 induced acute-phase protein production by a human hepatoma cell line, HEPG-2.
Topics: Acute-Phase Proteins; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Carcinoma, Hepatocellular; Complement C1 Inactivator Proteins; Fibrinogen; Humans; Interleukin-6; Liver Neoplasms; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Oligopeptides; Peptides; Tumor Cells, Cultured | 1995 |
IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells.
Topics: C-Reactive Protein; Carcinoma, Hepatocellular; Cells, Cultured; Fibrinogen; Humans; In Vitro Techniques; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Liver; Receptors, Interleukin-1; Serum Amyloid A Protein; Sialoglycoproteins; Tumor Necrosis Factor-alpha | 1995 |
The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: effects of IL-1 receptor antagonist (IL-1RA).
Topics: Arachidonic Acid; Carcinoma, Hepatocellular; Dinoprostone; Down-Regulation; Fibrinogen; Gene Expression; Humans; Indomethacin; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-6; Naproxen; Phospholipases A; Recombinant Proteins; RNA, Messenger; Sialoglycoproteins; Tumor Cells, Cultured | 1995 |
Fibrinogen, a vascular risk factor: a simple marker or a real cause of vascular lesion?
Topics: Adolescent; Adult; Biomarkers; Carcinoma, Hepatocellular; Cardiovascular Diseases; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Growth Inhibitors; Humans; Interleukin-6; Leukemia Inhibitory Factor; Liver; Liver Neoplasms; Lymphokines; Oncostatin M; Peptides; Recombinant Proteins; Risk Factors; Tumor Cells, Cultured | 1994 |
Synergism of interleukin 1 and interleukin 6 induces serum amyloid A production while depressing fibrinogen: a quantitative analysis.
Topics: Carcinoma, Hepatocellular; Culture Media, Conditioned; Cytokines; Drug Synergism; Fibrinogen; Gene Expression Regulation; Humans; Interleukin-1; Interleukin-6; Liver; Liver Neoplasms; Monocytes; Recombinant Proteins; Serum Amyloid A Protein; Tumor Cells, Cultured | 1994 |
Parotin subunit and its synthetic peptide possess interleukin 1-like activity and exert stimulating effects on liver cells and brain cells.
Topics: Adrenocorticotropic Hormone; Amino Acid Sequence; Animals; beta-Endorphin; Brain; Carcinoma, Hepatocellular; Cell Division; Cell Line; Fibrinogen; Globins; Humans; Interleukin-1; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Macromolecular Substances; Mice; Molecular Sequence Data; Peptide Fragments; Pituitary Neoplasms; Salivary Proteins and Peptides; Tumor Cells, Cultured | 1994 |
New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fibrinogen; Humans; Immunotherapy; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Picibanil; Prognosis | 1994 |
Characterization and immortalization of woodchuck hepatocytes isolated from normal and hepadnavirus-infected woodchucks (Marmota monax).
Topics: Albumins; Animals; Antigens, Viral, Tumor; Carcinoma, Hepatocellular; Cell Division; Cell Line, Transformed; Cell Separation; Cell Transformation, Viral; Complement C3; Culture Media, Serum-Free; Fibrinogen; Hepatitis B; Hepatitis B Virus, Woodchuck; Liver; Marmota; Nitric Oxide; Simian virus 40; Transferrin | 1994 |
Functional characterization of promoter elements involved in regulation of human B beta-fibrinogen expression. Evidence for binding of novel activator and repressor proteins.
Topics: Base Sequence; beta-Galactosidase; Carcinoma, Hepatocellular; Cell Line; Chloramphenicol O-Acetyltransferase; Consensus Sequence; Fibrinogen; Gene Expression Regulation; Humans; Liver Neoplasms; Molecular Sequence Data; Mutagenesis, Site-Directed; Nuclear Proteins; Plasmids; Promoter Regions, Genetic; Recombinant Fusion Proteins; Restriction Mapping; Tumor Cells, Cultured | 1993 |
Microencapsulated human hepatoma (HepG2) cells: in vitro growth and protein release.
Topics: alpha 1-Antitrypsin; Biocompatible Materials; Blood Proteins; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cell Survival; Collagen; Culture Techniques; Drug Combinations; Fibrinogen; Haptoglobins; Humans; Kinetics; Laminin; Liver Neoplasms; Methylmethacrylates; Neoplasm Proteins; Orosomucoid; Polyhydroxyethyl Methacrylate; Proteoglycans; Tumor Cells, Cultured | 1993 |
Molecular cloning and initial characterization of a novel fibrinogen-related gene, HFREP-1.
Topics: Amino Acid Sequence; Base Sequence; Carcinoma, Hepatocellular; DNA Probes; DNA, Neoplasm; Fibrinogen; Gene Library; Humans; Liver; Liver Neoplasms; Macromolecular Substances; Molecular Sequence Data; Neoplasm Proteins; Protein Sorting Signals; RNA, Messenger; Sequence Homology, Amino Acid; Tumor Cells, Cultured | 1993 |
[Efficacy of transarterial immuno-embolization therapy (TIE) in operable patients with hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Fibrinogen; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Picibanil; Thrombin | 1993 |
Effects of various fatty acids alone or combined with vitamin E on cell growth and fibrinogen concentration in the medium of HepG2 cells.
Topics: Carcinoma, Hepatocellular; Cell Division; Fatty Acids; Fibrinogen; Humans; Liver; Tumor Cells, Cultured; Vitamin E | 1995 |
The role of betagamma and alphagamma complexes in the assembly of human fibrinogen.
Topics: Animals; Carcinoma, Hepatocellular; Cell Fusion; Cell Line; Cricetinae; Dimerization; Fibrinogen; Humans; Kinetics; Liver Neoplasms; Macromolecular Substances; Polyethylene Glycols; Recombinant Proteins; Transfection | 1996 |
Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Cell Line; Dexamethasone; Epithelial Cells; Epithelium; Fibrinogen; Humans; Interleukin-6; Intestines; Kidney Neoplasms; Liver Neoplasms; Lung; Lung Neoplasms; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
A case of hepatocellular carcinoma with marked hyperfibrinogenemia.
Topics: Adult; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Fatal Outcome; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Immunoenzyme Techniques; Liver Neoplasms; Male; Neoplasm Proteins; Protein Precursors; Prothrombin | 1997 |
Lipoprotein (a) serum levels in patients with hepatocarcinoma.
Topics: Aged; Apolipoprotein B-100; Apolipoproteins B; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Lipoprotein(a); Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Serum Albumin | 1997 |
The sphingomyelin-ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid A, but not alpha-fibrinogen.
Topics: Apolipoproteins; Bridged-Ring Compounds; C-Reactive Protein; Carcinoma, Hepatocellular; Ceramides; Fibrinogen; Humans; Interleukin-1; Interleukin-6; Norbornanes; RNA, Messenger; Serum Amyloid A Protein; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingomyelins; Sphingosine; Thiocarbamates; Thiones; Tumor Cells, Cultured | 1997 |
[Transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fibrinogen; Hepatic Artery; Humans; Immunotherapy; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Picibanil; Thrombin | 1997 |
Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Copper; Female; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Zinc | 1997 |
Bezafibrate down-regulates fibrinogen biosynthesis in human hepatoma HepG2 cells.
Topics: Acute-Phase Reaction; Animals; Bezafibrate; Biological Transport; Carcinoma, Hepatocellular; Cattle; Dose-Response Relationship, Drug; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Fetal Blood; Fibrinogen; Humans; Intracellular Fluid; Lectins; Liver Neoplasms; Neoplasm Proteins; Precipitin Tests; RNA, Neoplasm; Tumor Cells, Cultured | 1998 |
Identification of a glucocorticoid response element in the human gamma chain fibrinogen promoter.
Topics: Animals; Carcinoma, Hepatocellular; Cloning, Molecular; Consensus Sequence; Dexamethasone; DNA Mutational Analysis; DNA-Binding Proteins; Fibrinogen; Gene Expression Regulation; Gene Library; Genetic Vectors; Humans; Liver Neoplasms; Mutagenesis, Site-Directed; Promoter Regions, Genetic; Rats; Receptors, Glucocorticoid; Recombinant Fusion Proteins; Tumor Cells, Cultured | 1998 |
Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
Topics: Animals; Carcinoma, Hepatocellular; Cells, Cultured; Fibrinogen; Gene Expression Regulation; Humans; Liver; Polymerase Chain Reaction; Proto-Oncogene Proteins c-jun; Rats; Receptors, Interleukin-6; RNA, Messenger; Solubility; Tumor Cells, Cultured | 1998 |
Interaction between heat shock and interleukin 6 stimulation in the acute-phase response of human hepatoma (HepG2) cells.
Topics: Acute-Phase Proteins; Carcinoma, Hepatocellular; Fibrinogen; Gene Expression Regulation, Neoplastic; Haptoglobins; Hot Temperature; Humans; Interleukin-6; Kinetics; Liver Neoplasms; Serum Albumin; Time Factors; Tumor Cells, Cultured | 1998 |
Synthesis, solution conformation and interleukin-6-related activities of interleukin-6 peptides.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Amino Acid Sequence; Carcinoma, Hepatocellular; Circular Dichroism; Complement Factor B; Fibrinogen; Humans; Interleukin-6; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Protein Conformation; Solutions; Tumor Cells, Cultured | 1998 |
Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism.
Topics: Carcinoma, Hepatocellular; DNA Probes; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Fibrinogens, Abnormal; Genes, Reporter; Humans; Liver Neoplasms; Luciferases; Point Mutation; Polymorphism, Genetic; Promoter Regions, Genetic; Trans-Activators; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1998 |
Regulation of angiogenin expression in human HepG2 hepatoma cells by mediators of the acute-phase response.
Topics: Acute-Phase Proteins; Carcinoma, Hepatocellular; Cytokines; Fibrinogen; Gene Expression Regulation; Humans; Interleukin-1; Interleukin-6; Proteins; Ribonuclease, Pancreatic; RNA, Messenger; Time Factors; Tumor Cells, Cultured | 1999 |
Effect of ciprofibrate on fibrinogen synthesis in vitro on hepatoma cells and in vivo in genetically obese Zucker rats.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Clofibric Acid; Dose-Response Relationship, Drug; Drug Antagonism; Fibric Acids; Fibrinogen; Humans; Hypolipidemic Agents; Interleukin-6; Liver Neoplasms; Obesity; Oncostatin M; Peptides; Rats; Rats, Zucker; Tumor Cells, Cultured | 1999 |
Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells.
Topics: Amidohydrolases; Breast Neoplasms; Carcinoma, Hepatocellular; Extracellular Matrix; Female; Fibrinogen; Glycosylation; Humans; Liver Neoplasms; Macromolecular Substances; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Tunicamycin | 2000 |
Pale bodies in hepatocellular carcinoma.
Topics: Albumins; Carcinoma, Hepatocellular; Cytoplasm; Endoplasmic Reticulum, Rough; Fibrinogen; Humans; Inclusion Bodies; Liver Neoplasms; Male; Microscopy, Electron; Middle Aged; Periodic Acid-Schiff Reaction | 2000 |
Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Disease-Free Survival; Embolization, Therapeutic; Female; Fibrinogen; Hepatectomy; Hepatic Artery; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Picibanil; Preoperative Care; Prognosis; Thrombin; Time Factors | 2001 |
C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells.
Topics: Carcinoma, Hepatocellular; Circular Dichroism; Fibrinogen; Humans; Interleukin-6; Liver Neoplasms; Models, Structural; Oligopeptides; Protein Structure, Tertiary; Proto-Oncogene Proteins c-jun; RNA, Messenger; Tumor Cells, Cultured | 2001 |
The alkaloids of Artabotrys uncinatus.
Topics: Alkaloids; Annonaceae; Antithrombins; Aporphines; Carcinoma, Hepatocellular; Chromatography, Thin Layer; Drug Screening Assays, Antitumor; Fibrinogen; Gas Chromatography-Mass Spectrometry; Heparin; Humans; Isoquinolines; Magnetic Resonance Spectroscopy; Medicine, Chinese Traditional; Molecular Conformation; Molecular Structure; Plant Leaves; Plant Roots; Plant Stems; Plants, Medicinal; Platelet Aggregation Inhibitors; Porphyrins; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Taiwan; Thrombin; Tumor Cells, Cultured | 2001 |
Intracellular synthesis of alpha-fetoprotein and fibrinogen without secretion by Zajdela rat ascites hepatoma cells.
Topics: alpha-Fetoproteins; Animals; Carcinoma, Hepatocellular; Fibrinogen; Liver Neoplasms; Male; Neoplasm Proteins; Neoplasms, Experimental; Rats | 1976 |
Blood coagulation and fibrinolysis in primary hepatima.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Carcinoma, Hepatocellular; Female; Fibrinogen; Fibrinolysis; Humans; Liver Neoplasms; Male; Middle Aged; Prothrombin; Thrombophlebitis | 1975 |
Measurement of fibrinogen degradation products (FDP) in serum of normal and tumor-bearing rats.
Topics: Animals; Carcinoma, Hepatocellular; Erythrocytes; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Immune Sera; Liver Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Transplantation, Homologous | 1975 |
Abnormal fibrin polymerization in liver disease.
Topics: Batroxobin; Blood Coagulation Tests; Carcinoma, Hepatocellular; Cholestasis; Chronic Disease; Fibrin; Fibrinogen; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polymers; Thrombin; Time Factors | 1976 |
Dysfibrinogenaemia and primary hepato-cellular carcinoma.
Topics: Adult; Afibrinogenemia; Batroxobin; Blood Coagulation Tests; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Liver Neoplasms; Male; Middle Aged; Serum Globulins | 1976 |
Coagulation abnormalities in liver disease.
Topics: Acute Disease; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Chronic Disease; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XIII; Fibrinogen; Hepatitis; Humans; Jaundice, Chronic Idiopathic; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Neoplasm Metastasis; Prothrombin; Vitamin K | 1977 |
Reptilase time in cirrhosis and hepatocellular carcinoma.
Topics: Batroxobin; Carcinoma, Hepatocellular; Fibrinogen; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Peptide Hydrolases | 1977 |
Hematological alterations in tumor-bearing rats, with reference to pathogenesis of chronic type of disseminated intravascular coagulation syndrome.
Topics: Animals; Blood Cell Count; Blood Coagulation; Carcinoma, Hepatocellular; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Liver Neoplasms; Male; Neoplasms, Experimental; Rats; Serum Albumin | 1977 |
Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Carbohydrates; Carcinoma, Hepatocellular; Fetal Blood; Fibrinogen; Humans; Liver Neoplasms; Neuraminidase; Sialic Acids | 1978 |
Transforming growth factor beta (TGF-beta) inhibits expression of fibrinogen and factor VII in a hepatoma cell line.
Topics: Carcinoma, Hepatocellular; Factor IX; Factor VII; Factor X; Fibrinogen; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Transforming Growth Factor beta; Tumor Cells, Cultured | 1992 |
[The efficacy of transarterial immuno-embolization therapy in patients with hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fibrinogen; Fluorouracil; Hepatic Artery; Humans; Immunotherapy; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Picibanil; Thrombin | 1992 |
Okadaic acid, an inhibitor of protein phosphatases 1 and 2A, inhibits induction of acute-phase proteins by interleukin-6 alone or in combination with interleukin-1 in human hepatoma cell lines.
Topics: Acute-Phase Proteins; C-Reactive Protein; Carcinoma, Hepatocellular; Cell Line; Dose-Response Relationship, Drug; Ethers, Cyclic; Fibrinogen; Humans; Interleukin-1; Interleukin-6; Kinetics; Liver Neoplasms; Okadaic Acid; Phosphoprotein Phosphatases; Protein Kinase C; Recombinant Proteins; Serum Amyloid A Protein; Signal Transduction | 1992 |
Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA.
Topics: Albumins; Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins A; Apolipoproteins B; Butyrates; Carcinoma, Hepatocellular; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Humans; Liver Neoplasms; Nucleic Acid Hybridization; RNA, Messenger; Tumor Cells, Cultured | 1991 |
Ethanol induces a1-protease inhibitor mRNA in Hep 3B cells.
Topics: alpha 1-Antitrypsin; Carcinoma, Hepatocellular; Cell Survival; Dose-Response Relationship, Drug; Ethanol; Fibrinogen; Humans; Liver Neoplasms; Osmolar Concentration; RNA, Messenger; Tumor Cells, Cultured | 1991 |
Constitutive plasminogen activator inhibitor 1 (PAI-1) biosynthesis in human Hep G2 hepatoma cells is maintained by an autocrine factor.
Topics: Biological Factors; Carcinoma, Hepatocellular; Culture Media; Fibrinogen; Humans; Interleukin-6; Liver Neoplasms; Plasminogen Inactivators; RNA, Messenger; Tumor Cells, Cultured | 1991 |
Transforming growth factor beta 1 regulates production of acute-phase proteins.
Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Carcinoma, Hepatocellular; Cell Line; Fibrinogen; Humans; Interleukin-6; Liver Neoplasms; Recombinant Proteins; RNA, Messenger; Transforming Growth Factors | 1990 |
Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines.
Topics: Acute-Phase Proteins; alpha 1-Antichymotrypsin; alpha-Fetoproteins; Carcinoma, Hepatocellular; Cytokines; Fibrinogen; Haptoglobins; Humans; In Vitro Techniques; Interleukin-1; Interleukin-6; Liver; Liver Neoplasms; Serum Albumin; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
Insulin modulation of acute-phase protein production in a human hepatoma cell line.
Topics: Acute-Phase Proteins; Carcinoma, Hepatocellular; Cell Line; Dexamethasone; Drug Synergism; Fibrinogen; Humans; Insulin; Interleukin-6; Tumor Cells, Cultured | 1991 |
Sandwich enzyme immunoassay for serum integrins using monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Glycoproteins; Hepatitis; Humans; Immunoblotting; Immunoenzyme Techniques; Integrins; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms; Platelet Membrane Glycoproteins; Receptors, Immunologic; Receptors, Vitronectin; Reference Values; Vitronectin | 1991 |
Hepatic neoplasms: effects of transcatheter arterial embolization on coagulation and fibrinolysis.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Carcinoma, Hepatocellular; Disseminated Intravascular Coagulation; Embolization, Therapeutic; Female; Fibrinogen; Fibrinolysis; Humans; Liver Neoplasms; Male; Middle Aged; Platelet Count | 1990 |
Studies on the structure and regulation of the human hepatic interleukin-6 receptor.
Topics: Carcinoma, Hepatocellular; Dexamethasone; Fibrinogen; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Interleukin-6; Liver Neoplasms; Receptors, Immunologic; Receptors, Interleukin-6; Recombinant Proteins; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 1990 |
Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; alpha-Fetoproteins; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Copper; Female; Fibrinogen; Hepatitis B Surface Antigens; Humans; Immunoenzyme Techniques; Liver; Liver Neoplasms; Male; Staining and Labeling | 1985 |
Tyrosine sulfation of proteins from the human hepatoma cell line HepG2.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Cell Line; Chromatography, Thin Layer; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Humans; Liver Neoplasms; Neoplasm Proteins; Protein Processing, Post-Translational; Tyrosine | 1985 |
The use of laser-nephelometry in evaluating fibrinogenaemia in patients with hepatocarcinoma and cirrhosis.
Topics: Carcinoma, Hepatocellular; Fibrinogen; Humans; Kinetics; Lasers; Liver Cirrhosis; Liver Neoplasms; Nephelometry and Turbidimetry | 1985 |
Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases.
Topics: Adult; Aged; Albumins; alpha-Fetoproteins; Carcinoma, Hepatocellular; Fibrinogen; Hepatitis B Surface Antigens; Histocytochemistry; Humans; Keratins; Liver Neoplasms; Middle Aged; Sarcoma; Time Factors; Vimentin | 1987 |
Inhibitory effect of human recombinant interferon gamma on synthesis of acute phase proteins in human hepatoma Hep G2 cells stimulated by leukocyte cytokines, TNF alpha and IFN-beta 2/BSF-2/IL-6.
Topics: Acute-Phase Proteins; Albumins; alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; alpha-Macroglobulins; Biological Factors; Blood Proteins; Carcinoma, Hepatocellular; Cytokines; Fibrinogen; Haptoglobins; Humans; Interferon Type I; Interferon-gamma; Liver Neoplasms; Neoplasm Proteins; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1988 |
Use of microcrystalline collagen powder and fibrinogen tissue adhesive for hemostasis and prevention of rebleeding in patients with hepatocellular carcinoma associated with cirrhosis of the liver.
Topics: Aprotinin; Carcinoma, Hepatocellular; Collagen; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Powders; Thrombin; Tissue Adhesives | 1989 |
Human hepatocyte-stimulating factor-III and interleukin-6 are structurally and immunologically distinct but regulate the production of the same acute phase plasma proteins.
Topics: Acute-Phase Proteins; Binding, Competitive; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Fibrinogen; Haptoglobins; Humans; Interleukin-6; Interleukins; Kinetics; Liver Neoplasms; Molecular Weight; Monocytes; Nucleic Acid Hybridization; Proteins; Receptors, Immunologic; Receptors, Interleukin-6; Recombinant Proteins; RNA, Messenger; Tumor Cells, Cultured | 1989 |
Endoplasmic storage disease of liver: characterization of intracytoplasmic hyaline inclusions.
Topics: Adult; Carcinoma, Hepatocellular; Complement C3; Complement C4; Endoplasmic Reticulum; Fibrinogen; Hepatitis B; Humans; Hyalin; Inclusion Bodies; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male | 1989 |
Sulfation of a gamma-chain variant of human fibrinogen.
Topics: Amino Acid Sequence; Carcinoma, Hepatocellular; Chromatography, Ion Exchange; Fibrinogen; Humans; Liver Neoplasms; Molecular Sequence Data; Precipitin Tests; Sequence Homology, Nucleic Acid; Sulfates; Tumor Cells, Cultured; Tyrosine | 1989 |
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Topics: Adenoma, Bile Duct; Adolescent; Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Immunoenzyme Techniques; Keratins; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1985 |
Monitoring liver regeneration after right hepatectomy.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Factor VII; Fibrinogen; Hepatectomy; Humans; Liver Neoplasms; Liver Regeneration; Male; Middle Aged; Postoperative Period; Prognosis; Prothrombin Time; Time Factors | 1985 |
A variant nuclear protein in dedifferentiated hepatoma cells binds to the same functional sequences in the beta fibrinogen gene promoter as HNF-1.
Topics: Animals; Carcinoma, Hepatocellular; DNA; Fibrinogen; Gene Expression Regulation; Hybrid Cells; Liver Neoplasms; Molecular Weight; Nuclear Proteins; Promoter Regions, Genetic; Rats; RNA, Messenger; Transcription Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1988 |
Fibrolamellar carcinoma as a cause of bile duct obstruction.
Topics: Adolescent; alpha 1-Antitrypsin; Carcinoma, Hepatocellular; Cholestasis, Extrahepatic; Cholestasis, Intrahepatic; Fibrinogen; Follow-Up Studies; Humans; Liver Neoplasms; Male | 1988 |
Diagnostic and prognostic value of serum copper and plasma fibrinogen in hepatic carcinoma.
Topics: Adenoma, Bile Duct; Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Copper; Diagnosis, Differential; Female; Fibrinogen; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 1985 |
Catabolic properties of aglycofibrinogen synthesized by tunicamycin-treated human hepatoma (HepG2) cells and rabbit hepatocytes.
Topics: Animals; Blood Coagulation; Carcinoma, Hepatocellular; Fibrinogen; Humans; Hydrolysis; Liver; Liver Neoplasms; Methionine; Oligosaccharides; Rabbits; Tunicamycin | 1986 |
[Fibrolamellar hepatocarcinoma with a long clinical course and possible production of fibrinogen].
Topics: Brain Neoplasms; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged | 1986 |
Endogenous forms of fibrinogen in Hep G2 cells.
Topics: Carcinoma, Hepatocellular; Cell Line; Fibrinogen; Humans; Iodoacetamide; Liver Neoplasms; Protein Conformation; Protein Precursors | 1987 |
Hepatocellular carcinoma with the carcinoid syndrome.
Topics: Acid Phosphatase; Adult; Albumins; Bile Acids and Salts; Carcinoma, Hepatocellular; Esterases; Fibrinogen; Glycogen; Histocytochemistry; Humans; Hydroxyindoleacetic Acid; Lipids; Lipoproteins; Liver Neoplasms; Lung Neoplasms; Male; Malignant Carcinoid Syndrome; Microscopy, Electron; Peroxidases; Serotonin; Staining and Labeling; Transferrin | 1971 |
Protein synthesis by the liver after transplantation.
Topics: Adult; Albumins; Carbon Isotopes; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Immunosuppressive Agents; Liver; Liver Function Tests; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Protein Biosynthesis; Time Factors; Transplantation, Homologous | 1970 |
Cryofibrinogenemia, multiple dysproteinemias, and hypervolemia in a patient with a primary hepatoma.
Topics: Blood Protein Disorders; Blood Volume; Carcinoma, Hepatocellular; Cold Temperature; Electrophoresis; Fibrinogen; Hematocrit; Immunoelectrophoresis; Liver Neoplasms; Neoplasm Metastasis; Spinal Cord Neoplasms | 1966 |
Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation.
Topics: Adult; Afibrinogenemia; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Carcinoma, Hepatocellular; Diagnosis, Differential; Female; Fibrin; Fibrinogen; Heparin; Hepatic Encephalopathy; Humans; Liver Neoplasms; Pregnancy; Pregnancy Complications; Prothrombin Time; Spectrophotometry; Thrombin | 1969 |
Abnormal fibrinogen synthesis questioned.
Topics: Carcinoma, Hepatocellular; Fibrinogen; Humans; Immunoelectrophoresis; Liver Neoplasms | 1969 |
Abnormal fibrinogen synthesis questioned.
Topics: Carcinoma, Hepatocellular; Fibrinogen; Humans; Immunoelectrophoresis; Liver Neoplasms | 1969 |
[Changes in the carbohydrate composition of fibrinogen in cases of acquired dysfibrinogenemia].
Topics: Blood Coagulation Disorders; Blood Protein Disorders; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Fibrinogen; Hexosamines; Hexoses; Humans; Jaundice; Liver Cirrhosis; Liver Neoplasms; Neuraminic Acids | 1970 |
Plasma fibrinogen in health and disease. Its application in the differential diagnosis of an enlarged and irregular liver.
Topics: Adult; Aged; Alcoholism; Carcinoma, Hepatocellular; Fatty Liver; Fibrinogen; Hepatomegaly; Humans; Intestinal Neoplasms; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1972 |
Plasma protein synthesis by N-2-fluorenylacetamide-induced primary hepatocellular carcinomas and hepatic nodules.
Topics: Acetamides; Animals; Autoradiography; Blood Proteins; Carcinogens; Carcinoma, Hepatocellular; Fibrinogen; Fluorenes; Haptoglobins; Immunoelectrophoresis; Liver Neoplasms; Male; Neoplasm Proteins; Neoplasms, Experimental; Rats; Transferrin | 1972 |
Dysfibrinogenaemia associated with primary hepatoma.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Chromatography, Gel; Female; Fibrin; Fibrinogen; Humans; Liver Neoplasms; Middle Aged; Prothrombin Time | 1972 |
[Synthesis of plasma proteins by cancerous and normal human hepatocytes in culture].
Topics: Biopsy, Needle; Blood Proteins; Carcinoma; Carcinoma, Hepatocellular; Cells, Cultured; Fibrinogen; Haptoglobins; Humans; Lipoproteins; Liver; Liver Neoplasms; Serum Albumin; Transferrin | 1974 |
[Relation between the cytotoxic and electrokinetic effect of human serum on L cells and Yoshida hepatoma ascites cells].
Topics: Animals; Carcinoma, Hepatocellular; Complement System Proteins; Electrophoresis; Fibrinogen; Guinea Pigs; Haptoglobins; Hemoglobins; Humans; Immune Sera; Immunoglobulins; L Cells; Liver Neoplasms; Neoplasms, Experimental; Rabbits; Rats; Serum Albumin | 1970 |